Clinical Trial Management Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028

Published on : Jun-2018 | List of Tables : 111 | List of Figures : 105 | No. of Pages : 250 | Report Code : FACT832MR | Format : ppt pdf Excel Word

Clinical trial management systems are central to eClinical environments, and considering the paramount focus on product safety and efficiency, there is a palpable shift towards better functionality and standardization. The clinical trial management systems market continues to be influenced by a range of factors – ranging from macroeconomic to industry-specific. On the back of a multi-pronged factors, the clinical trial management systems market is likely to tread along steadily during the assessment period.

Evolutions in Clinical Trial Management Systems Market

The evolutions in how clinical trials are conducted has meant that vendors are hard pressed to offer advanced solutions in addition to core functionalities such as site management, monitoring, and tracking. The need for innovation in clinical trials is also driven by mandates from regulatory authorities. Emphasis on transparency throughout the study process and adoption of risk-based approaches to clinical trial design influence the clinical trial management systems market.

clinical trial management systems market

Growing Use of SaaS Signifies a Shift in Clinical Trial Management Systems Market

The growing use of ‘Software as a Service (SaaS)’ system that enables web-based access to trial management systems signifies an undergoing shift in the clinical research industry. Web-based clinical trial management systems are becoming pervasive, and are expanding into new areas of clinical research. Although adopting web-based clinical trial management systems come with their own share of challenges, their benefits often outweigh the challenges.

‘Web-Based’ Accounts for Nearly 70% Revenue Share of Clinical Trial Management Systems Market

The penetration of web-based clinical trial management systems has grown manifold in the last five years or so. Access to information on a real-time basis, coupled with the feasibility of analyzing results quickly are among the leading factors that have fuelled adoption. The virtual storage option has given pharmaceutical and biotechnology companies the flexibility in terms of cost and computing power. It is no surprise then that web-based clinical trial management systems account for nearly 70% revenue share of the market. The preference for web-based clinical trial management systems is likely to continue during the assessment period as well. During the course of the review period, web-based clinical trial management systems will consistently hold nearly 70% revenue share.

The transition to web-based clinical trial management also gives end-users the tools to centralize computational and research tools. The flexibility, affordability, and advanced technology make web-based clinical trial management the preferred deployment model for end-users, however, challenges persist.

Clinical Trial Management Systems Market: Web-Based Vendors Need to Focus on Quelling Misplaced and Exaggerated Notions About Lack of Security

End-users have often a misplaced, exaggerated notion about the security apparatus of clinical trial management systems market. Although vendors have made investments in improving the security apparatus of web-based cloud security models, a concerted effort from all stakeholders is necessary if web-based clinical trial systems are to witness further penetration. Another key factor for clinical trial management systems to find the right vendors that is sensitive to the particular elements of life science and clinical trial data security and regulations. Of particular importance is compliance with FDA’s Title 21 Code of Federal Regulations. Regulatory compliance also entails standardization in approval from health services and insurance companies.

Future of Web-Based Clinical Trial Management Systems Market

Considering the slew of advantages clinical trial management systems have over traditional systems, the future belongs to web-based clinical trial management systems. The transition in the clinical trial management systems has been undergoing for some time now, and web-based procedures now account for a majority share of the market. However, it is also pertinent to mention that there is still a level of skepticism and reluctance in the clinical trial industry, especially in terms of data security and privacy. Availability of platforms and cloud-based products that utilize big data technology to optimize the cost of clinical development process can reduce some level of uncertainty.

Request research methodology of this report.

Essentiality of recording the varying requirements and imperative tasks of participants running a trail has driven the need for e-clinical framework, which is likely to become the master system of clinical trials as it evolves and integrates with other components of e-clinical continuum. Clinical trial management systems market (CTMS) will also be driven by increasing clinical trials outsourcing by pharmaceutical companies to contract research organizations (CROs) for execution, in a bid to enhance sourcing flexibility, meanwhile focusing on higher-priority activities such as drug discovery.

Clinical Trial Management Systems Market: Vendor Landscape

Prominent companies operating in the market, such as Cognizant, Veeva Systems, and Medidata, have greater footprint in North America, followed by APEJ on account of relatively higher demand in these regions. Although large companies operate in the market, their focus on CTMS solutions is currently low. However, future advancements and demand trends are likely to lead the market stakeholders to focus more on investment and development of CTMS solutions. Overall, the CTMS market will record an impressive expansion in the near future.

Detailed Assessment on Clinical Trial Management Systems Market

Fact.MR has recently developed a new research analysis on the clinical trial management system market, which exerts accurate forecasts on the market for the period between 2018 and 2027. This report is an explicit source of information, which imparts data on recent market dynamics, latest industry trends, potent markets, technology advancements & developments, and product innovation, along with an all-inclusive regional market coverage.

Comprehensive study on the clinical trial management system market is issued in the report, to help clients in attaining a competitive edge by attracting potential customers. This report further aids to better understand the market’s landscape, and propounds evaluations on the market’s competition intensity attractiveness. Intelligence engulfed in the report can be leveraged by the strategists to make fact-based business decisions.

Clinical Trial Management Systems Market: Taxonomy and Segmentation Analysis

This report offers a scrutinized analysis on the market for clinical trial management system based on a segmentation analysis. CTMS market is divided into four key segments, namely, product type, component, mode of deployment, and region. A detailed analysis has been offered on these segments, encompassing market estimates and forecasts based on a country as well as regional level.

Segmentation analysis offered is beneficial for the report readers to understand probable opportunities as well as potential markets for clinical trial management system. A taxonomy table provided in the report systematically demonstrates all the market segments.

Clinical Trial Management Systems Market: Research Methodology

A tested & proven research approach is employed by analysts at Fact.MR for evaluating key industry dynamics and offering precise and authentic market intelligence. A blend of primary & secondary research has been implemented for offering estimates and forecasts on the clinical trial management system market. Secondary research forms initial phase of our research, wherein the analysts conduct extensive information mining by referring to up-to-date and verified data resources that include technical journals, regulatory and government published material, and independent studies, which forms the basis of the market estimates.

All the market estimates and forecast offered are further verified via an exhaustive primary research, wherein interviews are conducted with leading market participants, and industry experts. These comprehensive primary interviews aid in validating the information procured and gain significant industry insights, estimations and key developments.

Chapter 1 Executive Summary

Chapter 2 Global Clinical Trial Management Systems Market Overview
2.1 Introduction
2.2 Market Definition
2.3 Scope of the report

Chapter 3 Market Dynamics
3.1 Key Growth Drivers
      3.1.1 The Role of CTMS in Improving Workflow
      3.1.2 Importance in the eClinical Framework
      3.1.3 Growing Importance of CTMS in eClinical Value Chain
      3.1.4 Streamlining Research Activities
3.2 Key Market Restraints
      3.2.1 Evolving Roadblocks
      3.2.2 Complex Trial Management
3.3 Opportunities
      3.3.1 Progress in Web Technology
      3.3.2 Increasing Biomedical Research Funding
      3.3.3 Key Trends
      3.3.4 Increasing Outsourcing Activities
      3.3.5 Growing Focus on Price and Modularity
      3.3.6 List of Key CTMS Software
3.4 CTMS Process Chain
      3.4.1 Investment Feasibility Analysis for CTMS
3.5 Market White Space and Wheel of Fortune Analysis
3.6 Product Life Cycle Analysis
3.7 Porter’s Five Forces Analysis
3.8 PESTLE Analysis

Chapter 4 Global Clinical Trial Management Systems Market Analysis
4.1 Global Market Outlook
      4.1.1 Market Forecast and Analysis
      4.1.2 Regional Demand Assessment
              4.1.2.1 Market Share by Region
4.2 Global CTMS Market Analysis by Mode of Deployment
      4.2.1 Forecast by Mode of Deployment
      4.2.2 Y-o-Y Growth Comparison by Mode of Deployment
      4.2.3 Market Attractiveness Analysis by Mode of Deployment
4.3 Global CTMS Market Analysis by Component
      4.3.1 Forecast by Component
      4.3.2 Y-o-Y Growth Comparison by Component
      4.3.3 Market Attractiveness Analysis by Component
4.4 Global CTMS Market Analysis by Product Type
      4.4.1 Forecast by Product Type
      4.4.2 Y-o-Y Growth Comparison by Product Type
      4.4.3 Market Attractiveness Analysis by Product Type
4.5 Global CTMS Market Analysis by End-user
      4.5.1 Forecast by End-user
      4.5.2 Y-o-Y Growth Comparison by End-user
      4.5.3 Market Attractiveness Analysis by End-user

Chapter 5 North America Clinical Trial Management Systems Market Analysis
5.1 North America Market Outlook
      5.1.1 Market Forecast and Analysis
      5.1.2 Impact Assessment of Market Forces
      5.1.3 Country Wise Demand Assessment
              5.1.3.1 Market Value Share by Country
5.2 North America CTMS Market Analysis by Mode of Deployment
      5.2.1 Forecast by Mode of Deployment
      5.2.2 Y-o-Y Growth Comparison by Mode of Deployment
5.3 North America CTMS Market Analysis by Component
      5.3.1 Forecast by Component
      5.3.2 Y-o-Y Growth Comparison by Component
5.4 North America CTMS Market Analysis by Product Type
      5.4.1 Forecast by Product Type
      5.4.2 Y-o-Y Growth Comparison by Product Type
5.5 North America CTMS Market Analysis by End-User
      5.5.1 Forecast by End-User
      5.5.2 Y-o-Y Growth Comparison by End-User

Chapter 6 Latin America Clinical Trial Management Systems Market Analysis
6.1 Latin America Market Outlook
      6.1.1 Market Forecast and Analysis
      6.1.2 Impact Assessment of Market Forces
      6.1.3 Country Wise Demand Assessment
              6.1.3.1 Market Value Share by Country
6.2 Latin America CTMS Market Analysis by Mode of Deployment
      6.2.1 Forecast by Mode of Deployment
      6.2.2 Y-o-Y Growth Comparison by Mode of Deployment
6.3 Latin America CTMS Market Analysis by Component
      6.3.1 Forecast by Component
      6.3.2 Y-o-Y Growth Comparison by Component
6.4 Latin America CTMS Market Analysis by Product Type
      6.4.1 Forecast by Product Type
      6.4.2 Y-o-Y Growth Comparison by Product Type
6.5 Latin America CTMS Market Analysis by End-User
      6.5.1 Forecast by End-User
      6.5.2 Y-o-Y Growth Comparison by End-User

Chapter 7 Europe Clinical Trial Management Systems Market Analysis
7.1 Europe Market Outlook
      7.1.1 Market Forecast and Analysis
      7.1.2 Impact Assessment of Market Forces
      7.1.3 Country Wise Demand Assessment
              7.1.3.1 Market Value Share by Country
7.2 Europe CTMS Market Analysis by Mode of Deployment
      7.2.1 Forecast by Mode of Deployment
      7.2.2 Y-o-Y Growth Comparison by Mode of Deployment
7.3 Europe CTMS Market Analysis by Component
      7.3.1 Forecast by Component
      7.3.2 Y-o-Y Growth Comparison by Component
7.4 Europe CTMS Market Analysis by Product Type
      7.4.1 Forecast by Product Type
      7.4.2 Y-o-Y Growth Comparison by Product Type
7.5 Europe CTMS Market Analysis by End-User
      7.5.1 Forecast by End-User
      7.5.2 Y-o-Y Growth Comparison by End-User

Chapter 8 Japan Clinical Trial Management Systems Market Analysis
8.1 Japan Market Outlook
      8.1.1 Market Forecast and Analysis
      8.1.2 Impact Assessment of Market Forces
8.2 Japan CTMS Market Analysis by Mode of Deployment
      8.2.1 Forecast by Mode of Deployment
      8.2.2 Y-o-Y Growth Comparison by Mode of Deployment
8.3 Japan CTMS Market Analysis by Component
      8.3.1 Forecast by Component
      8.3.2 Y-o-Y Growth Comparison by Component
8.4 Japan CTMS Market Analysis by Product Type
      8.4.1 Forecast by Product Type
      8.4.2 Y-o-Y Growth Comparison by Product Type
8.5 Japan CTMS Market Analysis by End-User
      8.5.1 Forecast by End-User
      8.5.2 Y-o-Y Growth Comparison by End-User

Chapter 9 APEJ Clinical Trial Management Systems Market Analysis
9.1 APEJ Market Outlook
      9.1.1 Market Forecast and Analysis
      9.1.2 Impact Assessment of Market Forces
      9.1.3 Country Wise Demand Assessment
      9.1.3.1 Market Value Share by Country
9.2 APEJ CTMS Market Analysis by Mode of Deployment
      9.2.1 Forecast by Mode of Deployment
      9.2.2 Y-o-Y Growth Comparison by Mode of Deployment
9.3 APEJ CTMS Market Analysis by Component
      9.3.1 Forecast by Component
      9.3.2 Y-o-Y Growth Comparison by Component
9.4 APEJ CTMS Market Analysis by Product Type
      9.4.1 Forecast by Product Type
      9.4.2 Y-o-Y Growth Comparison by Product Type
9.5 APEJ CTMS Market Analysis by End-User
      9.5.1 Forecast by End-User
      9.5.2 Y-o-Y Growth Comparison by End-User

Chapter 10 MEA Clinical Trial Management Systems Market Analysis
10.1 MEA Market Outlook
      10.1.1 Market Forecast and Analysis
      10.1.2 Impact Assessment of Market Forces
      10.1.3 Country Wise Demand Assessment
10.1.3.1 Market Value Share by Country
10.2 MEA CTMS Market Analysis by Mode of Deployment
      10.2.1 Forecast by Mode of Deployment
      10.2.2 Y-o-Y Growth Comparison by Mode of Deployment
10.3 MEA CTMS Market Analysis by Component
      10.3.1 Forecast by Component
      10.3.2 Y-o-Y Growth Comparison by Component
10.4 MEA CTMS Market Analysis by Product Type
      10.4.1 Forecast by Product Type
      10.4.2 Y-o-Y Growth Comparison by Product Type
10.5 MEA CTMS Market Analysis by End-User
      10.5.1 Forecast by End-User
      10.5.2 Y-o-Y Growth Comparison by End-User

Chapter 11 Competitive Assessment
11.1 Global CTMS Market- A Dashboard View
11.2 Global CTMS Market Structure
11.3 Global CTMS market Company Share Analysis
11.4 For Tier 1 Market Players, 2017
11.5 Company Share Analysis- By Mode of Deployment
11.6 Company Market Share Analysis of Top key Players, By Region
11.7 Competition Matrix

Chapter 12 Company Profiles
12.1 Medidata Solutions
      12.1.1 Operational Facilities Across Globe, 2017
      12.1.2 Region Wise Share of CTMS Product – Company Benchmark
      12.1.3 Company Revenue Share, By Mode of Deployment
      12.1.4 Company Revenue Share, By Component
      12.1.5 Key Developments
      12.1.6 Key Financials
      12.1.7 SWOT Analysis
12.2 PAREXEL International Inc.
      12.2.1 Operational Facilities Across Globe, 2017
      12.2.2 Region Wise Share of CTMS Product – Company Benchmark
      12.2.3 Company Revenue Share, By Mode of Deployment
      12.2.4 Company Revenue Share, By Component
      12.2.5 Key Developments
            12.2.6 Key Financials
      12.2.7 SWOT Analysis
12.3 International Business Machines Corporation (IBM)
      12.3.1 Operational Facilities Across Globe, 2017
      12.3.2 Region Wise Share of CTMS Product – Company Benchmark
      12.3.3 Company Revenue Share, By Mode of Deployment
      12.3.4 Company Revenue Share, By Component
      12.3.5 Key Developments
      12.3.6 Key Financials
      12.3.7 SWOT Analysis
12.4 Bioclinica
      12.4.1 Operational Facilities Across Globe, 2017
      12.4.2 Region Wise Share of CTMS Product – Company Benchmark
      12.4.3 Company Revenue Share, By Mode of Deployment
      12.4.4 Company Revenue Share, By Component
      12.4.5 Recent Key Developments
      12.4.6 SWOT Analysis
12.5 Oracle Corporation
      12.5.1 Operational Facilities Across Globe, 2017
      12.5.2 Region Wise Share of CTMS Product – Company Benchmark
      12.5.3 Company Revenue Share, By Mode of Deployment
      12.5.4 Company Revenue Share, By Component
      12.5.5 Key Developments
      12.5.6 Key Financials
      12.5.7 SWOT Analysis
12.6 Cognizant Technology Solutions Corporation
      12.6.1 Operational Facilities Across Globe, 2017
      12.6.2 Region Wise Share of CTMS Product – Company Benchmark
      12.6.3 Company Revenue Share, By Mode of Deployment
      12.6.4 Company Revenue Share, By Component
      12.6.5 Key Developements
      12.6.6 Key Financials
      12.6.7 SWOT Analysis
12.7 DSG, Inc.
      12.7.1 Operational Facilities Across Globe, 2017
      12.7.2 Region Wise Share of CTMS Product – Company Benchmark
      12.7.3 Company Revenue Share, By Mode of Deployment
      12.7.4 Company Revenue Share, By Component
      12.7.5 Key Developments
12.8 Forte Research Systems, Inc.
      12.8.1 Operational Facilities Across Globe, 2017
      12.8.2 Region Wise Share of CTMS Product – Company Benchmark
      12.8.3 Company Revenue Share, By Mode of Deployment
      12.8.4 Company Revenue Share, By Component
      12.8.5 Key Developments
12.9 Veeva Systems
      12.9.1 Operational Facilities Across Globe, 2017
      12.9.2 Region Wise Share of CTMS Product – Company Benchmark
      12.9.3 Company Revenue Share, By Mode of Deployment
      12.9.4 Company Revenue Share, By Component
      12.9.5 Key Developments
      12.9.6 Key Financials
12.10 Bio-Optronics, Inc.
      12.10.1 Operational Facilities Across Globe, 2017
      12.10.2 Region Wise Share of CTMS Product – Company Benchmark
      12.10.3 Company Revenue Share, By Mode of Deployment
      12.10.4 Company Revenue Share, By Component
      12.10.5 Key Developments
12.11 DATATRAK International, Inc.
      12.11.1 Operational Facilities Across Globe, 2017
      12.11.2 Region Wise Share of CTMS Product – Company Benchmark
      12.11.3 Company Revenue Share, By Mode of Deployment
      12.11.4 Company Revenue Share, By Component
      12.11.5 Key Developments
12.12 MedNet Solutions, Inc.
      12.12.1 Operational Facilities Across Globe, 2017
      12.12.2 Region Wise Share of CTMS Product – Company Benchmark
      12.12.3 Company Revenue Share, By Mode of Deployment
      12.12.4 Company Revenue Share, By Component
      12.12.5 Key Developments
12.13 ArisGlobal Software Private Limited
      12.13.1 Operational Facilities Across Globe, 2017
      12.13.2 Region Wise Share of CTMS Product – Company Benchmark
      12.13.3 Company Revenue Share, By Mode of Deployment
      12.13.4 Company Revenue Share, By Component
      12.13.5 Key Developments

Chapter 13 Appendix

Chapter 14 Disclaimer and Contact information

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Clinical Trial Management Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028